Arcturus Therapeutics Holdings Inc

NASDAQ:ARCT   4:00:00 PM EDT
33.77
+0.91 (+2.77%)
6:35:25 PM EDT: $33.82 +0.05 (+0.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)908.93M
Current PEN/A
Forward PE N/A
2yr Forward PE 225.13
See more stats
Estimates Current Quarter
Revenue$15.85 Million
Adjusted EPS-$1.69
See more estimates
10-Day MA$34.06
50-Day MA$36.09
200-Day MA$29.70
See more pivots

Arcturus Therapeutics Holdings Inc Stock, NASDAQ:ARCT

10628 Science Center Drive, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.900.2660
Number of Employees: 180

Description

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.